2013
DOI: 10.1016/j.nano.2012.11.004
|View full text |Cite
|
Sign up to set email alerts
|

Curcumin-conjugated nanoliposomes with high affinity for Aβ deposits: Possible applications to Alzheimer disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
78
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 139 publications
(79 citation statements)
references
References 35 publications
0
78
0
Order By: Relevance
“…In this way, intracranial injection of liposomes encapsulating curcumin efficiently labeled Aβ deposits in both human and mice tissues, proving to be an effective formulation for diagnosis and treatment of AD. 113 Also, intraperitoneal injection of liposomes containing phosphatidic acid or cardiolipin was able to reduce Aβ peptides in the plasma and shifted the equilibrium that exists between brain and blood Aβ peptides, slightly affecting the plaques in the brain. 89 Lastly, different liposome-based vaccines were developed and directed toward Aβ plaques 115,116 and tau.…”
Section: Data Extractionmentioning
confidence: 99%
See 1 more Smart Citation
“…In this way, intracranial injection of liposomes encapsulating curcumin efficiently labeled Aβ deposits in both human and mice tissues, proving to be an effective formulation for diagnosis and treatment of AD. 113 Also, intraperitoneal injection of liposomes containing phosphatidic acid or cardiolipin was able to reduce Aβ peptides in the plasma and shifted the equilibrium that exists between brain and blood Aβ peptides, slightly affecting the plaques in the brain. 89 Lastly, different liposome-based vaccines were developed and directed toward Aβ plaques 115,116 and tau.…”
Section: Data Extractionmentioning
confidence: 99%
“…84,85 Although the scope of this review is on liposome-strategies with the aim of facilitating BBB crossing, it is important to mention that other strategies have been developed for the use of liposomes for AD treatment. 89,[113][114][115][116] Curcumin is a natural compound extract from the plant Curcuma longa, and has been reported to be a fluorescent molecule with high affinity for the Aβ peptide and able to reduce Aβ aggregation. In this way, intracranial injection of liposomes encapsulating curcumin efficiently labeled Aβ deposits in both human and mice tissues, proving to be an effective formulation for diagnosis and treatment of AD.…”
Section: Data Extractionmentioning
confidence: 99%
“…Oxidative damage and inflammatory processes are known to be particularly high in the brains of Alzheimer patients, and as the aqueous extract of turmeric reduces and prevents oxidation, it may be used concurrently in long-term therapy (46)(47)(48)(49).…”
Section: Antioxidant Activitymentioning
confidence: 99%
“…It is a polyphenolic ingredient which is considered as major antioxidant, coloring and flavoring agent in the balanced diet (Yao et al 2011). Several studies have been published reporting pluripotent pharmacolological actions of Curcumin e.g., anticancer (Ketron and Osheroff 2014), antiretroviral (Barthelemy et al 1998), antiinflammatory (Kant et al 2014), antidiabetic (Zhang et al 2013), antidepressant (Pathak et al 2013), anti-alzheimer (Lazar et al 2013), antioxidant (Khalil and Ali 2011), antibacterial (Gunes et al 2013), antifungal (Sharma 2012) etc. These varied medicinal benefits also suggest application of this extraordinary molecule as a functional food (nutraceutical) ingredient.…”
Section: Introductionmentioning
confidence: 99%